×

Thiophene integrin inhibitors

  • US 6,274,620 B1
  • Filed: 06/07/2000
  • Issued: 08/14/2001
  • Est. Priority Date: 06/07/1999
  • Status: Expired due to Fees
First Claim
Patent Images

1. A compound of formula I:

  • and pharmaceutically acceptable salts thereof, wherein;

    X is selected from the group consisting of O and S;

    Y1 is selected from the group consisting of O, S and N;

    W is selected from the group consisting of carbonyl and sulfonyl;

    R1 and R2 are independently selected from the group consisting of H, C5-10aryl, C5-10arylsulfonylamino, C5-10cycloalkylsulfonylamino, C5-10arylamino and C5-10arylC1-6alkyl with the proviso that R1 and R2 are not both H;

    R3 is selected from the group consisting of H, C1-8alkyl, C1-8alkylamino C0-8alkyl, C1-8alkoxy, C1-8alkylepoxy C1-8alkylC1-8alkyl-Y2C(O)Y3

    C0-8alkyl, C5-8aryl, C5-8arylC0-8alkyl-Y2C(O)Y3

    C0-8alkyl, C5-8aryl, C1-8alkylC5-8aryl, and C5-8arylC1-8alkyl, wherein Y2 and Y3 are independently O or N;

    R4 and R5 are independently selected from the group consisting of H, halogen, C1-6alkyl and C1-6alkoxy;

    A is selected from the group consisting of C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C5-10aryl, C3-10cycloakyl; and

    B is selected from the group consisting of amino, C1-6aminoalkyl, C5-10arylamino, guanidino, C1-6guanidinoalkyl, cyclic guanidino, urea, cyclic urea.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×